Q3 FY2024 · ended Oct 31, 2023 · Revenue $1,311, -94.4% YoY · Filed Dec 15, 2023
Neutra Corp. (NTRR) files with the SEC under industry code 2833, Medicinal Chemicals & Botanical Products. In Q3 of fiscal 2024, the quarter ended Oct 31, 2023, it reported revenue of $1,311 and a net loss of $54,986.
Revenue
$1,311
-94.4% vs year-ago quarter
Net income
$-54,986
+32.8% vs year-ago quarter
Operating cash flow
$-442
+98.1% vs year-ago quarter
Free cash flow
$-53,002
EPS
—
Dividend per share
None
Shares outstanding
2.92B
+26.8% vs year-ago quarter
Net cash
—
Operating margin
-1457.1%
TTM
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- NTRR (OTC)
- Fiscal year ends
- January 31
- Incorporated in
- WY
- Headquarters
- Houston, TX
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1512886
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2024 Oct 31, 2023 |
Q2 FY2024 Jul 31, 2023 |
Q1 FY2024 Apr 30, 2023 |
Q4 FY2023 Jan 31, 2023 |
Q3 FY2023 Oct 31, 2022 |
|---|---|---|---|---|---|
| Revenue | $1,311 | $4,325 | $5,842 | $5,919 | $23,383 |
| Operating income | -$52,728 | -$71,769 | -$71,208 | -$57,789 | -$66,074 |
| Net income | -$54,986 | -$71,847 | -$71,996 | -$275,003 | -$81,792 |
| Operating cash flow | -$442 | -$2,004 | -$8,831 | $1,513 | -$23,225 |
| Total assets | $26,944 | $36,942 | $54,104 | $75,175 | $97,963 |
| Total liabilities | $962,984 | $917,996 | $863,311 | $813,795 | $1.3M |
| Stockholders' equity | -$936,040 | -$881,054 | -$809,207 | -$773,820 | -$1.3M |
| Cash and investments | $692 | $1,134 | $3,138 | $1,969 | $456 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 7, 2024 | Apr 30, 2024 |
| 10-K | Annual report | Aug 2, 2024 | Jan 31, 2024 |
| 8-K |
Current report
Auditor change
|
May 15, 2024 | May 3, 2024 |
| 10-Q | Quarterly report | Dec 15, 2023 | Oct 31, 2023 |
| 10-Q | Quarterly report | Sep 14, 2023 | Jul 31, 2023 |
| 8-K |
Current report
Auditor change
|
Aug 4, 2023 | Aug 1, 2023 |
All 160 Neutra Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.